Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

25.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
25.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.1K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Red cell antigen exposures in patients with sickle cell disease receiving transfusion from Black and Hispanic donors.

Blood. Red cells & iron·2026
Same author

Isovolemic hemodilution red cell exchange and blood use in children and young adults with sickle cell disease.

Blood. Red cells & iron·2026
Same author

Inflammation, anemia, and vitamin D levels associate with infant thrombocytosis risk.

Research and practice in thrombosis and haemostasis·2026
Same author

Tropomyosin 1 Promotes Platelet Adhesion and Clot Contraction Separate from Its Roles in Developmental Hematopoiesis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Identification of breakpoint regions and single nucleotide variations of RHD hybrid alleles by long-read sequencing.

Vox sanguinis·2026
Same author

Cross-species comparison of platelet proteomes reveals developmentally regulated metabolic and inflammatory changes.

Blood vessels, thrombosis & hemostasis·2026
Same journal

Cytotoxicity Modulated by Cyanotoxins in Neuroblastoma SH-SY5Y Cells.

Journal of Experimental Pathology·2025
Same journal

News About the Extracellular Vesicles from Mesenchymal Stem Cells: Functions, Therapy and Protection from COVID-19.

Journal of Experimental Pathology·2021
Same journal

Succinate Accumulation Links Mitochondrial MnSOD Depletion to Aberrant Nuclear DNA Methylation and Altered Cell Fate.

Journal of Experimental Pathology·2021
Same journal

New observations on the distribution of an old and forgotten model of enteritis in rats.

Journal of experimental pathology·1992
Same journal

The antagonistic effect of interferon-beta on the interferon-gamma-induced expression of HLA-DR antigen in a squamous cell carcinoma line.

Journal of experimental pathology·1992
Same journal

Neurotoxic effects of platinum compounds in cultured dorsal root ganglion cells.

Journal of experimental pathology·1992
See all related articles

Related Experiment Video

Updated: Nov 11, 2025

Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation
09:57

Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation

Published on: December 21, 2016

14.8K

Mechanistic and Translational Advances Using iPSC-Derived Blood Cells.

Christopher S Thom1, Stella T Chou2, Deborah L French3

  • 1Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Journal of Experimental Pathology
|March 26, 2021
PubMed
Summary
This summary is machine-generated.

Induced pluripotent stem cell (iPSC) models are advancing the study of blood disorders and neurodegenerative diseases. These models use iPSC-derived blood cells to investigate conditions like anemia, leukemia, and Alzheimer's disease.

Keywords:
AnemiaCancerDevelopmental biologyHematopoiesisImmunodeficiencyThrombosisiPSC

More Related Videos

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

3.0K
Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

13.0K

Related Experiment Videos

Last Updated: Nov 11, 2025

Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation
09:57

Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation

Published on: December 21, 2016

14.8K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

3.0K
Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

13.0K

Area of Science:

  • Stem cell biology
  • Hematology
  • Neuroscience

Background:

  • Induced pluripotent stem cells (iPSCs) offer a powerful tool for disease modeling.
  • Hematopoietic stem cells and their derivatives are crucial for understanding blood disorders.
  • Microglial cells play a key role in neurodegenerative diseases.

Purpose of the Study:

  • To review recent advances in using iPSC-derived blood cells for modeling hematopoietic disorders.
  • To discuss the impact of iPSC-derived microglial cells on neurodegenerative disease research.
  • To highlight the translational utility of iPSC models in various diseases.

Main Methods:

  • Utilizing iPSC-derived red blood cells, megakaryocytes, myeloid cells, and lymphoid cells.
  • Differentiating iPSC-derived monocytes into microglial cells for neurodegenerative disease modeling.
  • Reviewing recent studies and translational insights.

Main Results:

  • iPSC-derived blood cells effectively model a range of hematopoietic disorders.
  • iPSC-derived microglial cells provide insights into neurodegenerative disease mechanisms.
  • iPSC models demonstrate utility for studying anemia, bleeding, thrombosis, autoimmunity, immunodeficiency, blood cancers, and Alzheimer's disease.

Conclusions:

  • iPSC-based model systems are valuable for studying hematopoietic and non-hematologic disorders.
  • These models offer significant translational potential for drug discovery and therapeutic development.
  • Further research using iPSC-derived cells will advance understanding and treatment of complex diseases.